Medivation

Medivation Inc.: Today's Featured Drugs Laggard

Medivation Inc.: Today's Featured Drugs Laggard

The Street

Medivation

Medivation Earnings: Your Sneak Peek to the Big Announcement

Medivation Earnings: Your Sneak Peek to the Big Announcement

Wall St. Cheat Sheet

This Week in Biotech

This Week in Biotech

Motley Fool

Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation

Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation

Yahoo/Minyanville

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Can Bristol-Myers Squibb Compete In Immuno-Oncology?

Seeking Alpha

Medivation, Astellas Pharma provide update on Phase 3 PREVAIL

Medivation, Astellas Pharma provide update on Phase 3 PREVAIL

Yahoo/Fly on the Wall

Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Motley Fool

Medivation Earnings Call Nuggets: Gross to Net Conversion and the Pre-Chemo Market

Medivation Earnings Call Nuggets: Gross to Net Conversion and the Pre-Chemo Market

Wall Street Cheat Street

1 Overblown Biotech Selloff

1 Overblown Biotech Selloff

Motley Fool

Medivation